Novo Nordisk

6 posts in this category

FDA Approves Wegovy HD: What the New Higher-Dose GLP-1 Injection Means for Weight Loss

Wegovy HD (7.2 mg) is now FDA-approved with 20.7% average weight loss. Learn about results, effects, availability, and how it compares to Zepbound.

Apr 6, 2026

FDA Sends Warning Letter to Novo Nordisk Over Unreported GLP-1 Deaths and Side Effects

The FDA warned Novo Nordisk for not reporting deaths and serious side effects tied to its GLP-1 medications. Here is what happened.

Mar 21, 2026

people-laughing-while-walking-exercising

The Novo Nordisk and Hims Deal: What It Means for GLP-1 Pricing and Access

Novo Nordisk and Hims struck a deal on Ozempic and Wegovy pricing. See what it means for GLP-1 costs, compounded access, and your options.

Mar 13, 2026

If Ozempic Costs $3 to Make, Why Does It Cost $900?

GLP-1 shots cost under $5 to make but sell for $900+. See what drives the price, whether it's justified, and how pricing is changing in 2026.

Mar 11, 2026

The Wegovy Pill Is Live: What It Means For You In 2026

The oral Wegovy pill is now available for weight management. Learn how it works, who it helps most, how it compares with injectables, and next steps.

Jan 16, 2026

FDA Warns Against Unapproved GLP-1 Drugs for Weight Loss

The FDA warned about counterfeit Ozempic, research peptides, and retatrutide. Medications should be prescribed and filled by state-licensed pharmacies

Dec 18, 2024